Home/Filings/4/0001437749-25-035186
4//SEC Filing

PICKER DONALD H 4

Accession 0001437749-25-035186

CIK 0001659617other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 4:08 PM ET

Size

7.8 KB

Accession

0001437749-25-035186

Insider Transaction Report

Form 4
Period: 2025-11-12
Transactions
  • Award

    Stock option (right to buy)

    2025-11-12+200,000295,508 total
    Exercise: $0.49Exp: 2035-11-12Common Stock (200,000 underlying)
  • Award

    Performance Based Restricted Stock Units

    2025-11-12+200,000495,508 total
    Exp: 2035-11-12Common Stock (200,000 underlying)
Footnotes (4)
  • [F1]The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.
  • [F2]Issued in connection with the reporting person's employment with the Company.
  • [F3]Each restricted stock unit represents a contingent right to receive one shares of Company common stock.
  • [F4]On November 12, 2025, the Board approved this performance based restricted stock unit. The performance based restricted stock units set forth in this table will vest in 20% installments upon the achievement of certain clinical milestones; provided that upon a change of control (as defined in the 2024 Stock Plan) 100% shall vest.

Issuer

Moleculin Biotech, Inc.

CIK 0001659617

Entity typeother

Related Parties

1
  • filerCIK 0001266800

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:08 PM ET
Size
7.8 KB